Title | Creator | ||
---|---|---|---|
101 | Hypercoagulable States in Ophthalmology | Andrew G. Lee, MD; Dina Zamil | |
102 | Neuro-Ophthalmology and the Kidneys | Andrew G. Lee, MD; Dina Zamil | |
103 | Hashimoto's Encephalopathy | Andrew G. Lee, MD; Jeremy Auerbach | |
104 | Hypertension and Neuro-Ophthalmology | Andrew G. Lee, MD; Hannah Wang | |
105 | Nonartertic Anterior Ischemic Optic Neuropathy (NAION) | Andrew G. Lee, MD; Hongan Hannah Chen | |
106 | Gaze Evoked Amaurosis | Andrew G. Lee, MD; Jonathan Go | |
107 | Giant Cell Arteritis (GCA) Unusual Presentations | Andrew G. Lee, MD; Jonathan Go | |
108 | Infranuclear Cranial Motor Neuropathy | Andrew G. Lee, MD; Jonathan Go | |
109 | Optical Coherence Tomography (OCT) in Neuro-Ophthalmology | Andrew G. Lee, MD; Jason Zehden | |
110 | Neurocysticercosis | Andrew G. Lee, MD; Kristen Brown | |
111 | Optic Nerve Tumors | Andrew G. Lee, MD; Kevin Chen | |
112 | Ocular Neuromyotonia | Andrew G. Lee, MD; Kara Shannon | |
113 | Homonymous Hemianopsia with no Structural Correlate | Andrew G. Lee, MD; Jeffrey Lee | |
114 | Incomplete Third Nerve Palsy Approach | Andrew G. Lee, MD; Nicole Weber | |
115 | Neurocysticercosis | Andrew G. Lee, MD; Nicole Weber | |
116 | Multiple Endocrine Neoplasia (MEN) and the Eye | Andrew G. Lee, MD; Priyanka Deshpande | |
117 | Ophthalmic Manifestations of Parkinsons Disease | Andrew G. Lee, MD; Priyanka Deshpande | |
118 | Hydroxychloroquine Toxicity and Screening | Andrew G. Lee, MD; Lauren Nakhleh | |
119 | Nonparetic Diplopia | Andrew G. Lee, MD; Lauren Nakhleh | |
120 | Ocular Myasthenia Gravis | Andrew G. Lee, MD; Pauline Berens | |
121 | Lymphocytic Hypophysitis | Andrew G. Lee, MD; Nasim Khalfe | |
122 | Guillain-Barre Syndrome (GBS) | Andrew G. Lee, MD; Maxwell Lee | |
123 | Idiopathic Intracranial Hypertension (IIH) | Andrew G. Lee, MD; Paarth Kapadia | |
124 | Lymphocytic Hypophysitis | Andrew G. Lee, MD; Prraneeth Kambhampati | |
125 | Non-Organic Vision Loss | Andrew G. Lee, MD; Philip Zhou |